AbbVie Bid for Biotech Could Expand with Experimental Drug
AbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Knowing when to use financial planning services can significantly impact your financial health. Discover the right timing for assistance.
24,264 articlesAbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Nvidia sits at the center of a rapid AI infrastructure buildout. Here’s how the stock could move by 2029, based on gr...
MAGY, the MAGY Magnificent Seven Covered Call ETF, now offers a Monday-morning income payout. The fund uses an active...
Bitcoin price crashes below the key $60,000 level as MicroStrategy shares slide, signaling renewed pressure across di...
Arm Holdings trades around $347 as investors weigh AI-driven demand and data-center opportunities. Analysts see a pat...
A veteran journalist says that while IPO chatter around OpenAI persists, the path to a public listing is longer and m...
Investors woke up to a move in Comcast shares after strategic news and improving fundamentals. This article breaks do...
A Nasdaq-listed firm disclosed it liquidated its entire Bitcoin position, raising questions about the future of crypt...
Coinbase stock faces a tough year, but cost reductions and a rebound in crypto activity could spark a meaningful rall...
Prediction markets are painting a different picture from AI headlines, placing Anthropic ahead of OpenAI for a 2026 l...
Colorado regulators announced a settlement with Unlock Technologies to reclassify home equity agreements as consumer ...
Internal briefings show top Iranian figures told the Supreme Leader the US naval blockade is crushing the economy, pr...